CD28 signaling domain boosts persistence and in vivo anti-tumor activity of stem cell-derived CD19-CAR-NK cells

Sadeleştirilmiş öğe sayfası
dc.contributor.authorKok, Nina
dc.contributor.authorOzkazanc, Didem
dc.contributor.authorvan Vliet, Amanda A.
dc.contributor.authorSteenmans, Danielle
dc.contributor.authorSingh, Simar Pal
dc.contributor.authorSutlu, Tolga
dc.contributor.authorGeorgoudaki, Anna\\-Maria
dc.contributor.authorRaimo, Monica
dc.contributor.authorSpanholtz, Jan
dc.contributor.authorDuru, Adil Doganay
dc.date.accessioned2025-10-16T15:11:42Z
dc.date.issued2025
dc.identifier.doi10.1016/j.isci.2025.112548
dc.identifier.otherWOS:001496973900001
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/4947
dc.publisherCELL PRESS
dc.sourceISCIENCE
dc.subjectHighlights
dc.subjectNatural sciences
dc.subjectBiological sciences
dc.titleCD28 signaling domain boosts persistence and in vivo anti-tumor activity of stem cell-derived CD19-CAR-NK cells
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS